Search Results
Aug 10, 2026, 09:15 ET Abbott Lanza una Campaña en Español con Gabriela Spanic para Fomentar la Detección del Cáncer de Colon con Cologuard Plus®
https://www.cancer.org/cancer/types/colon-rectal-cancer/detection-diagnosis-staging/survival-rates.html3 Siegel RL, Wagle NS, Star J, et al. Colorectal cancer statistics, 2026. CA Cancer J Clin. 2026;e70067.4 Cologuard Plus Clinician Brochure. Exact Sciences Corporation. Madison, WI.5 Guardant Health.
More news about: Abbott
Aug 05, 2026, 08:17 ET Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology
transcription factor protected cfDNA in plasma by ChIP-seq: measurement of altered CTCF binding in cancer is a novel biomarker for liquid biopsy. Clin Epigenet (2026). https://doi.org/10.1186/s13148-026-02205-xData
More news about: VolitionRx Limited
Aug 04, 2026, 16:01 ET Rigel Reports Second Quarter 2026 Financial Results
https://www.cancer.org/cancer/types/lung-cancer/about/key-statistics.htmlKato, S. et al. RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients. Clin Cancer Res. 2017;23(8):1988-1997 doi: 10.1158/1078-0432.CCR-16-1679The American Cancer Society. Key Statistics for Acute Myeloid Leukemia (AML).
More news about: Rigel Pharmaceuticals, Inc.
Aug 03, 2026, 07:45 ET Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer
this release.Endnotes & ReferencesSiegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12-49. doi:10.3322/caac.21820[SEER] Surveillance, Epidemiology, and End Results (SEER). Cancer stat facts: pancreatic cancer.
More news about: Eli Lilly and Company
Jul 30, 2026, 19:50 ET U.S. Renal Care Drives Innovation in Dialysis with Increased Availability of Medium Cut-Off Dialyzers to Support Expanded Hemodialysis
10.1093/ndt/gfaa322.4 Weiner DE, Falzon L, Skoufos L, et al. Efficacy and safety of expanded hemodialysis with the Theranova 400 dialyzer: A randomized controlled trial. Clin J Am Soc Nephrol. 2020;15(9):1310-1319. doi:10.2215/CJN.01210120. PMID: 32843372; PMCID: PMC7480550. 5 Garcia-Prieto, CKJ, 2018.
More news about: U.S. Renal Care
Jul 30, 2026, 16:05 ET Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer
2021;161(1):113-121. 7. Vergote I, et al. J Clin Oncol. 2023;41(35):5400-5410. 8. Mirza
More news about: Karyopharm Therapeutics Inc.
Jul 30, 2026, 08:30 ET Johnson & Johnson's RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer
Oncol. 2025;171:107791.3 Kalyankrishna S, Grandis JR. Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol. 2006;24(17):2666–2672.4 Burtness B, Rosenberg AJ, Calderon B, et al. Amivantamab in recurrent/metastatic head and neck
More news about: Johnson & Johnson
Jul 29, 2026, 07:00 ET CalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints
www.calcimedica.com.ReferencesGandhirajan RK, et al. Blockade of NOX2 and STIM1 signaling limits lipopolysaccharide-induced vascular inflammation. J Clin Invest. 2013;123(2):887-902.Kosuru R, et al. Rap1A controls store-operated calcium entry and lung inflammation via Orai1 regulation. Arterioscler
More news about: CalciMedica, Inc.
Jul 24, 2026, 09:00 ET Advita Ortho Announces First Clinical Use of Equinoxe® Reverse Shoulder System Humeral Liners with Activit-E® Polyethylene
Natural Polyphenols Enhance Stability of Crosslinked UHMWPE for Joint Implants. Clin Orthop Relat Res. 2014 Aug 9;473(3):760–766. doi: 10.1007/s11999-014-3850-0.Activit-E polyethylene and Equinoxe Reverse Shoulder System
More news about: Advita Ortho, LLC
Jul 24, 2026, 08:30 ET Roche receives FDA clearance for the cobas® BV/CV assay, enabling fast and highly accurate vaginitis diagnosis
Molecular Diagnosis of Vaginitis: Comparing Quantitative PCR and Microbiome Profiling Approaches to Current Microscopy Scoring. J Clin Microbiol. August 26, 2019; 57(9):e00300-19. doi: 10.1128/JCM.00300-19. PMID: 31315951; PMCID: PMC6711928.Melo, et al.
More news about: Roche
Jul 23, 2026, 08:30 ET TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma
https://www.cancer.org/cancer/types/multiple-myeloma/detection-diagnosis-staging/detection.html9 Kazandjian D. Multiple myeloma epidemiology and survival: a unique malignancy. J Clin Oncol. 2018;36(15):1479-1487.
More news about: Johnson & Johnson
Jul 23, 2026, 02:08 ET Haisco's Class 1 Innovative Drug Ciprocopan Succinate Tablets Approved in China, Offering a New Treatment Option for Patients With PNH
Succinate Tablets;Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296-1310.Risitano AM, et al. Br J Haematol. 2022;196:288-303.Hillmen P, et al. N Engl J Med. 2006;355:1233-1243.Peffault
More news about: Haisco Pharmaceutical Group Co., Ltd.
Jul 22, 2026, 13:58 ET Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer
Target in Non–Small-Cell Lung Cancer. J Clin Oncol 33, 972-974(2015).5 Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74(3): 229-263. doi:10.3322/caac.218346 GSK
More news about: GSK plc
Jul 21, 2026, 09:15 ET ORASIS PHARMACEUTICALS DOUBLES DOWN ON EYE CARE PROFESSIONALS, NOT TELEHEALTH, AS QLOSI® REFILLS REACH 49%¹
al. Efficacy and Safety of CSF-1 (0.4% Pilocarpine Hydrochloride) in Presbyopia: Pooled Results of the NEAR Phase 3 Randomized, Clinical Trials. Clin Ther. 2024;46(2):104-113. doi:10.1016/j.clinthera.2023.12.005.5 Holden, B. A., et al. Global Vision Impairment Due to Uncorrected
More news about: ORASIS PHARMACEUTICALS
Jul 17, 2026, 01:25 ET Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
LARFerone, D., et al. Octreotide subcutaneous depot for acromegaly: A randomized, double-blind, placebo-controlled phase 3 trial, ACROINNOVA 1. J Clin Endocrinol Metab. Published 8 October, 2024.
More news about: Camurus AB
Jul 17, 2026, 01:22 ET Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
LARFerone, D., et al. Octreotide subcutaneous depot for acromegaly: A randomized, double-blind, placebo-controlled phase 3 trial, ACROINNOVA 1. J Clin Endocrinol Metab. Published 8 October, 2024.
More news about: Camurus AB
Jul 16, 2026, 08:00 ET Canopy and Rocky Mountain Cancer Centers Announce Multi-Year Partnership to Improve Care with Enterprise AI
remote therapeutic monitoring with patient-reported outcomes on hospitalization in real-world patients receiving therapy for metastatic solid tumors. J Clin Oncol. 2026;44(suppl 16):abstr 11005. doi:10.1200/JCO.2026.44.16_suppl.110052 Derman BA, Kolodziej MA, Essell JH, et al. Impact of
More news about: Canopy
Jul 15, 2026, 09:15 ET ORASIS PHARMACEUTICALS ANNOUNCES AUSTRALIA SUBMISSION OF A NEW DRUG APPLICATION FOR BESKA FOR THE TREATMENT OF PRESBYOPIA
al. Efficacy and Safety of CSF-1 (0.4% Pilocarpine Hydrochloride) in Presbyopia: Pooled Results of the NEAR Phase 3 Randomized, Clinical Trials. Clin Ther. 2024;46(2):104-113. doi:10.1016/j.clinthera.2023.12.005.
More news about: ORASIS PHARMACEUTICALS
Jul 14, 2026, 05:02 ET Le concert BML2026 rassemble une prestigieuse sélection des principales franchises de jeux vidéo de style anime en Chine
communautés de joueurs. Plus de 110 000 personnes s'étaient préinscrites sur Bilibili avant l'ouverture des ventes, et les billets se sont vendus en un clin d'œil.Le concert a été diffusé en direct le 12 juillet sur le compte officiel de Bilibili, atteignant une audience maximale de 45 millions de
More news about: Bilibili
Jul 07, 2026, 08:00 ET Kenai Therapeutics Announces Completion of Enrollment in Phase 1b/2a REPLACE™ Trial of RNDP-001 in Idiopathic Parkinson's Disease
Regenerative Medicine (CIRM), a state of California Agency that funds regenerative medicine, stem cell, and gene therapy research. (Grant Numbers CLIN1-14300; CLIN2-19068).RNDP-001 is an investigational cell therapy that has not been approved by any regulatory authority, and its efficacy and safety have
More news about: Kenai Therapeutics/BIOCOM
Jul 04, 2026, 14:01 ET BEYONCÉ SORT UNE NOUVELLE CHANSON, « MORNING DEW (DONK) » : CETTE JOURNÉE DU 4 JUILLET EST UN VÉRITABLE RÉGAL POUR SES FANS
Beyoncé et Pharrell Williams, « MORNING DEW (DONK) » est le premier nouveau titre proposé par l'artiste internationale depuis deux ans, et il s'agit d'un clin d'œil direct à ses fidèles fans, les BeyHive, pour célébrer la prochaine grande fête de B'DAY.Cette chanson, qui figurera sur l'édition 20e Anniversary
More news about: Parkwood Entertainment
Jul 02, 2026, 06:30 ET Partner Therapeutics Announces Publication of Results From the eNRGy Trial of Zenocutuzumab in Patients with NRG1+ Cholangiocarcinoma in Journal of Clinical Oncology (JCO)
al. Efficacy and tolerability of zenocutuzumab in advanced NRG1 fusion-positive cholangiocarcinoma: Results from the eNRGy phase 2 trial. J Clin Oncol. 2026. doi:
More news about: Partner Therapeutics, Inc.
Jun 29, 2026, 21:00 ET Casio s'apprête à lancer une montre EDIFICE mécanique à remontage automatique dont l'aspect évolue en fonction de la lumière
première montre mécanique automatique de Casio, l'EFK-100, avait rencontré un tel succès après son lancement l'année dernière qu'elle s'est vendue en un clin d'œil sur les marchés du monde entier.La nouvelle EFK-200 à mouvement automatique se distingue par un boîtier aux lignes courbes, polie avec
More news about: CASIO COMPUTER CO., LTD
Jun 29, 2026, 03:00 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo
2020;33(6):778-787. doi:10.1111/pcmr.12878Birlea SA, Goldstein NB, Norris DA. Repigmentation through melanocyte regeneration in vitiligo. Dermatol Clin. 2017;35(2):205-218. doi:10.1016/j.det.2016.11.015van Geel N, Speeckaert R, Taïeb A, et al. Worldwide expert recommendations for the diagnosis
More news about: AbbVie
Jun 29, 2026, 03:00 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo
2020;33(6):778-787. doi:10.1111/pcmr.12878Birlea SA, Goldstein NB, Norris DA. Repigmentation through melanocyte regeneration in vitiligo. Dermatol Clin. 2017;35(2):205-218. doi:10.1016/j.det.2016.11.015van Geel N, Speeckaert R, Taïeb A, et al. Worldwide expert recommendations for the diagnosis
More news about: AbbVie